Bihua Chen - 12 Jun 2024 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
Director, 10%+ Owner
Signature
/s/ Bihua Chen
Issuer symbol
BMEA
Transactions as of
12 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 16:38:16 UTC
Previous filing
13 Feb 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMEA Common Stock 3,570,872 12 Jun 2024 See Footnotes F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMEA Stock Option (right to buy) Award $0 +51,025 $0.000000 51 12 Jun 2024 Common Stock 51,025 $4.63 Direct F4, F5
holding BMEA Stock Option (right to buy) 28,911 12 Jun 2024 Common Stock 28,911 $17.00 Direct F3, F4
holding BMEA Stock Option (right to buy) 23,867 12 Jun 2024 Common Stock 23,867 $10.20 Direct F4, F5
holding BMEA Stock Option (right to buy) 6,989 12 Jun 2024 Common Stock 6,989 $38.90 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP (the "Fund III"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund III, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F2 Represents (i) 1,795,928 shares of Common Stock held by the Master Fund, (ii) 1,717,232 shares of Common Stock held by Fund III, and (iii) 57,712 shares of Common Stock held by the Account.
F3 The options were granted with a 36 month vesting period, vesting monthly.
F4 Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.
F5 The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date.